Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.30 |
| ▸ | CYP21A2 | P08686 | 2/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.30 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28941794 | 0.82 | — | — | |
| Ethyne SCHEMBL28053649 | 0.79 | — | — | |
| SCHEMBL19665087 | 0.78 | CA12 (0.50) | CA12CA1CA9CES2CES1 | |
| Hydrazine SCHEMBL29093630 | 0.76 | IDO1 (0.36) | CA12CA1CA9CES2CES1 | |
| Acetic Acid SCHEMBL7536061 | 0.73 | CES2 (0.42) | CA12CA1CA9CES2CES1 | |
| SCHEMBL12562821 | 0.69 | SLC6A4 (0.45) | CA12CA1CA9CES2CES1 | |
| SCHEMBL13699010 | 0.69 | ALDH1A1 (0.53) | ESR2NOTUM | |
| SCHEMBL6389956 | 0.69 | CA9 (0.43) | CA12CA1CA9CES2CES1 | |
| SCHEMBL28784067 | 0.69 | CA12 (0.30) | CA12CA1CA9 | |
| SCHEMBL29319682 | 0.69 | CA12 (0.67) | CA12CA1CA9CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080105865-A1 | Pyrene Based Compound and Light Emitting Transistor Element Using the Same | PIONEER CORPORATION (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1816114-A1 | PYRENE COMPOUND AND LIGHT EMITTING TRANSISTOR DEVICE UTILIZING THE SAME | Rohm Co., Ltd. (JP) | 2007-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080105865-A1 | Pyrene Based Compound and Light Emitting Transistor Element Using the Same | CYP1A1, SULT1A1, SULT1E1 | CA12 4496/4885CA1 3601/4885CA9 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.